G W Telega1, D C Baumgart, S R Carding. 1. Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, USA.
Abstract
BACKGROUND & AIMS: The immunoregulatory properties of primary colonic epithelial cells (CECs) have not been defined. The ability of CECs from wild-type and interleukin 2-deficient (IL-2(-/-)) mice to take up a complex protein antigen and present peptides via MHC molecules to T cells was assessed and contrasted with that of primary small intestinal epithelial cells (SIECs). METHODS: Uptake of fluorescein isothiocyanate (FITC)-labeled ovalbumin (FITC-OVA) by CECs and SIECs from wild-type and IL-2(-/-) mice was measured by flow cytometry. The effect of disrupting cytoskeleton organization and metabolic activity of CEC on antigen uptake was assessed. An OVA/I-A(b)-specific CD4(+) T-cell line transfected with an NFAT-lacZ reporter gene construct was used to evaluate the ability of CECs and SIECs as well as CECs from healthy and colitic IL-2(-/-) mice to present antigen to T cells. RESULTS: Uptake of FITC-OVA by CECs is concentration dependent, is not saturated at physiologic concentrations, and requires metabolically active cells. CECs from IL-2(-/-) mice take up significantly more antigen than those from wild-type mice. CECs are more efficient APCs than SIECs, and antigen-pulsed CECs from IL-2(-/-) mice induce the highest levels of T-cell activation. CONCLUSIONS: Primary CECs are efficient APCs for CD4 MHC class II-restricted T cells. Antigen uptake and presentation is up-regulated in animals prone to develop intestinal inflammation.
BACKGROUND & AIMS: The immunoregulatory properties of primary colonic epithelial cells (CECs) have not been defined. The ability of CECs from wild-type and interleukin 2-deficient (IL-2(-/-)) mice to take up a complex protein antigen and present peptides via MHC molecules to T cells was assessed and contrasted with that of primary small intestinal epithelial cells (SIECs). METHODS: Uptake of fluorescein isothiocyanate (FITC)-labeled ovalbumin (FITC-OVA) by CECs and SIECs from wild-type and IL-2(-/-) mice was measured by flow cytometry. The effect of disrupting cytoskeleton organization and metabolic activity of CEC on antigen uptake was assessed. An OVA/I-A(b)-specific CD4(+) T-cell line transfected with an NFAT-lacZ reporter gene construct was used to evaluate the ability of CECs and SIECs as well as CECs from healthy and colitic IL-2(-/-) mice to present antigen to T cells. RESULTS: Uptake of FITC-OVA by CECs is concentration dependent, is not saturated at physiologic concentrations, and requires metabolically active cells. CECs from IL-2(-/-) mice take up significantly more antigen than those from wild-type mice. CECs are more efficient APCs than SIECs, and antigen-pulsed CECs from IL-2(-/-) mice induce the highest levels of T-cell activation. CONCLUSIONS: Primary CECs are efficient APCs for CD4 MHC class II-restricted T cells. Antigen uptake and presentation is up-regulated in animals prone to develop intestinal inflammation.
Authors: Daniel J Mulder; Aman Pooni; Nanette Mak; David J Hurlbut; Sameh Basta; Christopher J Justinich Journal: Am J Pathol Date: 2011-02 Impact factor: 4.307
Authors: Mathew P Swerdlow; Douglas R Kennedy; Jeffrey S Kennedy; Robert J Washabau; Paula S Henthorn; Peter F Moore; Simon R Carding; Peter J Felsburg Journal: Vet Immunol Immunopathol Date: 2006-10-05 Impact factor: 2.046
Authors: M Ningappa; C Ashokkumar; B W Higgs; Q Sun; R Jaffe; G Mazariegos; D Li; D E Weeks; S Subramaniam; R Ferrell; H Hakonarson; R Sindhi Journal: Am J Transplant Date: 2015-12-11 Impact factor: 8.086
Authors: Semir Beyaz; Charlie Chung; Haiwei Mou; Khristian E Bauer-Rowe; Michael E Xifaras; Ilgin Ergin; Lenka Dohnalova; Moshe Biton; Karthik Shekhar; Onur Eskiocak; Katherine Papciak; Kadir Ozler; Mohammad Almeqdadi; Brian Yueh; Miriam Fein; Damodaran Annamalai; Eider Valle-Encinas; Aysegul Erdemir; Karoline Dogum; Vyom Shah; Aybuke Alici-Garipcan; Hannah V Meyer; Deniz M Özata; Eran Elinav; Alper Kucukural; Pawan Kumar; Jeremy P McAleer; James G Fox; Christoph A Thaiss; Aviv Regev; Jatin Roper; Stuart H Orkin; Ömer H Yilmaz Journal: Cell Stem Cell Date: 2021-09-15 Impact factor: 25.269